MED.DE XETRA
Mediclin AG
1W: -4.7%
1M: -7.3%
3M: +26.9%
YTD: +32.1%
1Y: +70.0%
3Y: +77.1%
5Y: +33.9%
€5.10 ($5.70)
-0.00 (-0.00%)
Weekly Expected Move ±3.9%
€5
€5
€5
€5
€5
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$880M
-2.9% ▼
5Y CAGR: -0.2%
Total Liabilities
$630M
-7.8% ▼
5Y CAGR: -2.4%
Shareholders Equity
$249M
+11.9% ▲
5Y CAGR: +7.0%
Cash & Investments
$72M
-32.9% ▼
5Y CAGR: -6.4%
Total Debt
$377M
-18.8% ▼
5Y CAGR: -5.0%
Net Debt
$305M
-14.5% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $120M | $88M | $115M | $108M | $72M |
| Short-Term Investments | $14M | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $133M | $88M | $115M | $108M | $72M |
| Net Receivables | $112M | $140M | $153M | $180M | $182M |
| Inventory | $9M | $9M | $7M | $8M | $5M |
| Other Current Assets | $25M | $24M | $96M | $77K | $4M |
| Total Current Assets | $266M | $262M | $300M | $298M | $263M |
| Property, Plant & Equip. | $508M | $544M | $514M | $533M | $503M |
| Goodwill & Intangibles | $57M | $56M | $23M | $25M | $17M |
| Long-Term Investments | -$13M | $43M | $67K | $39M | $26M |
| Other Non-Current Assets | $53M | $721K | $91M | $566K | $21M |
| Total Non-Current Assets | $615M | $654M | $639M | $608M | $617M |
| Total Assets | $881M | $916M | $881M | $906M | $880M |
| — Liabilities — | |||||
| Accounts Payable | $13M | $14M | $13M | $13M | $15M |
| Short-Term Debt | $27M | $27M | $27M | $2M | $28M |
| Deferred Revenue | $93M | $105M | $1M | $0 | $0 |
| Other Current Liabilities | $54M | $58M | $69M | $69M | $104M |
| Total Current Liabilities | $213M | $171M | $171M | $166M | $163M |
| Long-Term Debt | $69M | $68M | $66M | $65M | $0 |
| Other Non-Current Liab. | $127M | $83M | $84M | $81M | $80M |
| Total Non-Current Liabilities | $485M | $536M | $513M | $517M | $467M |
| Total Liabilities | $698M | $707M | $684M | $683M | $630M |
| — Equity — | |||||
| Common Stock | $48M | $48M | $48M | $48M | $0 |
| Retained Earnings | $6M | $32M | -$16M | $8M | $81M |
| Accumulated OCI | $21M | $38M | $35M | $48K | $0 |
| Total Stockholders Equity | $183M | $209M | $196M | $223M | $249M |
| Total Liabilities & Equity | $881M | $916M | $881M | $906M | $880M |
| — Key Metrics — | |||||
| Total Debt | $440M | $503M | $480M | $464M | $377M |
| Net Debt | $320M | $415M | $365M | $357M | $305M |
| Total Investments | $847K | $43M | $67K | $39M | $26M |